Walsh LF, Lee RP, Pan J, Dutta AB, Kaduluri VPS, Li HL, Abrams Z, Payne P, Imus PH, Ambinder AJ, Dalton WB, DeZern AE, Gojo I, Jain T, Karatanos T, Prince G, Smith BD, Webster JA, Gondek L, Levis M, Ghiaur G. Metronomic decitabine with venetoclax offers a patient-centered frontline therapeutic approach for TP53-mutated complex-karyotype myeloid neoplasms. haematol [Internet]. 2020Sep.10 [cited 2026Oct.19];. Available from: https://haematologica.org/article/view/14491